Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barrington J.A. Furr"'
Autor:
V. Craig Jordan, Barrington J.A. Furr
Publikováno v:
Hormone Therapy in Breast and Prostate Cancer ISBN: 9781607614715
The reduction of circulating steroid hormones or the blockade of steroid action in cancer tissue are primary goals in the current strategy of breast- and prostate-cancer treatment. Antiestrogens, antiandrogens, aromatase inhibitors, and highly potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fb2b77fab2392f79477f745af3cf019
https://doi.org/10.1007/978-1-59259-152-7_1
https://doi.org/10.1007/978-1-59259-152-7_1
Autor:
V. Craig Jordan, Barrington J.A. Furr
Publikováno v:
Hormone Therapy in Breast and Prostate Cancer ISBN: 9781607614715
The goal of this final chapter is to highlight several important advances in basic and clinical research that may prove to be pivotal advances for the new millenium. Although it is not possible to be all-inclusive, we have selected advances that coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a83e6501c97273b5bd94d9d0819b89
https://doi.org/10.1007/978-1-59259-152-7_18
https://doi.org/10.1007/978-1-59259-152-7_18
Publikováno v:
Urologic Clinics of North America. 18:99-110
SUMMARY Pure anti-androgens have advantages over steroidal anti-androgens of the cyproterone acetate type in the treatment of patients with advanced prostate cancer because they do not have steroidal side effects or such a marked inhibitory effect on
Autor:
Barrington J.A. Furr
Publikováno v:
Aromatase Inhibitors ISBN: 9783764371999
Aromatase Inhibitors ISBN: 9783764386924
Aromatase Inhibitors ISBN: 9783764386924
Several excellent chapters in this book describe the clinical utility of aromatase inhibitors in the treatment of breast cancer. It is true to say that use of third-generation aromatase inhibitors has had a major therapeutic impact: emerging clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93df04ba3b5a4c078fb4d7a2bae41e90
https://doi.org/10.1007/3-7643-7418-7_9
https://doi.org/10.1007/3-7643-7418-7_9
Autor:
Barrington J.A. Furr, V. Craig Jordan
Publikováno v:
Hormone Therapy in Breast and Prostate Cancer
An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer V. Craig Jordan and Barrington J. A. Furr Part I. Preclinical Antiestrogens Antiestrogens and the Cell Cycle Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f5db58f99d42f7918974d5eea1ba02
https://doi.org/10.1007/978-1-59259-152-7
https://doi.org/10.1007/978-1-59259-152-7
Publikováno v:
Steroids. 65(10-11)
From the dual progestin/antiandrogenic properties of certain synthetic steroids (e.g. cyproterone acetate), it was apparent that the progesterone (P) and androgen (A) receptors must have some common ligand binding features. The nonsteroidal antiandro
Publikováno v:
European Journal of Cancer (1965). 15:755-761
The transplantable mammary carcinoma (LMC 1 ) of John's Strain Wistar rat did not respond to either 50 μg tamoxifen daily or bilateral ovariectomy. This failure to inhibit growth, correlated with a very low level of [ 3 H ]oestradiol binding capacit